PH30243A - Parenteral dosage form - Google Patents
Parenteral dosage formInfo
- Publication number
- PH30243A PH30243A PH42634A PH42634A PH30243A PH 30243 A PH30243 A PH 30243A PH 42634 A PH42634 A PH 42634A PH 42634 A PH42634 A PH 42634A PH 30243 A PH30243 A PH 30243A
- Authority
- PH
- Philippines
- Prior art keywords
- carrier
- drug
- microspheres
- recipient
- mixt
- Prior art date
Links
- 239000006201 parenteral dosage form Substances 0.000 title 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 4
- 229940079593 drug Drugs 0.000 abstract 4
- 239000003814 drug Substances 0.000 abstract 4
- 239000004005 microsphere Substances 0.000 abstract 3
- 235000012000 cholesterol Nutrition 0.000 abstract 2
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 abstract 2
- 239000011261 inert gas Substances 0.000 abstract 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 abstract 2
- 239000007787 solid Substances 0.000 abstract 2
- RXPRRQLKFXBCSJ-GIVPXCGWSA-N vincamine Chemical compound C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C[C@](O)(C(=O)OC)N5C2=C1 RXPRRQLKFXBCSJ-GIVPXCGWSA-N 0.000 abstract 2
- DIWRORZWFLOCLC-HNNXBMFYSA-N (3s)-7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one Chemical compound N([C@H](C(NC1=CC=C(Cl)C=C11)=O)O)=C1C1=CC=CC=C1Cl DIWRORZWFLOCLC-HNNXBMFYSA-N 0.000 abstract 1
- FQRHOOHLUYHMGG-BTJKTKAUSA-N 3-(2-acetylphenothiazin-10-yl)propyl-dimethylazanium;(z)-4-hydroxy-4-oxobut-2-enoate Chemical compound OC(=O)\C=C/C(O)=O.C1=C(C(C)=O)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 FQRHOOHLUYHMGG-BTJKTKAUSA-N 0.000 abstract 1
- 108010007979 Glycocholic Acid Proteins 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- RFDAIACWWDREDC-UHFFFAOYSA-N Na salt-Glycocholic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCC(O)=O)C)C1(C)C(O)C2 RFDAIACWWDREDC-UHFFFAOYSA-N 0.000 abstract 1
- HWHLPVGTWGOCJO-UHFFFAOYSA-N Trihexyphenidyl Chemical group C1CCCCC1C(C=1C=CC=CC=1)(O)CCN1CCCCC1 HWHLPVGTWGOCJO-UHFFFAOYSA-N 0.000 abstract 1
- 229960001946 acepromazine maleate Drugs 0.000 abstract 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 abstract 1
- YSXKPIUOCJLQIE-UHFFFAOYSA-N biperiden Chemical compound C1C(C=C2)CC2C1C(C=1C=CC=CC=1)(O)CCN1CCCCC1 YSXKPIUOCJLQIE-UHFFFAOYSA-N 0.000 abstract 1
- 229960003003 biperiden Drugs 0.000 abstract 1
- DGBIGWXXNGSACT-UHFFFAOYSA-N clonazepam Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)CN=C1C1=CC=CC=C1Cl DGBIGWXXNGSACT-UHFFFAOYSA-N 0.000 abstract 1
- 229960003120 clonazepam Drugs 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- QYIXCDOBOSTCEI-NWKZBHTNSA-N coprostanol Chemical compound C([C@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-NWKZBHTNSA-N 0.000 abstract 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 abstract 1
- 229960003529 diazepam Drugs 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- RXPRRQLKFXBCSJ-UHFFFAOYSA-N dl-Vincamin Natural products C1=CC=C2C(CCN3CCC4)=C5C3C4(CC)CC(O)(C(=O)OC)N5C2=C1 RXPRRQLKFXBCSJ-UHFFFAOYSA-N 0.000 abstract 1
- 229960001253 domperidone Drugs 0.000 abstract 1
- FGXWKSZFVQUSTL-UHFFFAOYSA-N domperidone Chemical compound C12=CC=CC=C2NC(=O)N1CCCN(CC1)CCC1N1C2=CC=C(Cl)C=C2NC1=O FGXWKSZFVQUSTL-UHFFFAOYSA-N 0.000 abstract 1
- RFDAIACWWDREDC-FRVQLJSFSA-N glycocholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 RFDAIACWWDREDC-FRVQLJSFSA-N 0.000 abstract 1
- 229940099347 glycocholic acid Drugs 0.000 abstract 1
- 229960003878 haloperidol Drugs 0.000 abstract 1
- 229960004391 lorazepam Drugs 0.000 abstract 1
- 239000000155 melt Substances 0.000 abstract 1
- 238000002844 melting Methods 0.000 abstract 1
- 230000008018 melting Effects 0.000 abstract 1
- 229960004503 metoclopramide Drugs 0.000 abstract 1
- TTWJBBZEZQICBI-UHFFFAOYSA-N metoclopramide Chemical compound CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC TTWJBBZEZQICBI-UHFFFAOYSA-N 0.000 abstract 1
- 229960005181 morphine Drugs 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 239000007921 spray Substances 0.000 abstract 1
- 238000005507 spraying Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 229960001032 trihexyphenidyl Drugs 0.000 abstract 1
- 229960002726 vincamine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compounds Of Unknown Constitution (AREA)
- Steroid Compounds (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9007417A FR2663224B1 (fr) | 1990-06-14 | 1990-06-14 | Forme galenique parenterale. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH30243A true PH30243A (en) | 1997-02-05 |
Family
ID=9397599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH42634A PH30243A (en) | 1990-06-14 | 1991-06-14 | Parenteral dosage form |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US5643604A (cs) |
| EP (1) | EP0487674B1 (cs) |
| JP (1) | JP2690398B2 (cs) |
| KR (1) | KR0157438B1 (cs) |
| CN (1) | CN1058608C (cs) |
| AT (1) | ATE117546T1 (cs) |
| AU (1) | AU643540B2 (cs) |
| BG (1) | BG61178B1 (cs) |
| BR (1) | BR9105782A (cs) |
| CA (1) | CA2064861C (cs) |
| CZ (1) | CZ286199B6 (cs) |
| DE (1) | DE69107026T2 (cs) |
| DK (1) | DK0487674T3 (cs) |
| ES (1) | ES2068592T3 (cs) |
| FI (1) | FI107697B (cs) |
| FR (1) | FR2663224B1 (cs) |
| GR (1) | GR3015809T3 (cs) |
| HU (1) | HU219461B (cs) |
| IE (1) | IE69172B1 (cs) |
| IL (1) | IL98458A (cs) |
| NO (2) | NO920576L (cs) |
| NZ (1) | NZ238543A (cs) |
| PH (1) | PH30243A (cs) |
| PL (1) | PL167177B1 (cs) |
| PT (1) | PT97976B (cs) |
| RO (1) | RO110198B1 (cs) |
| RU (1) | RU2095055C1 (cs) |
| SK (1) | SK279867B6 (cs) |
| TN (1) | TNSN91047A1 (cs) |
| TW (1) | TW205511B (cs) |
| UY (1) | UY23239A1 (cs) |
| WO (1) | WO1991019485A1 (cs) |
| ZA (1) | ZA914549B (cs) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5981719A (en) | 1993-03-09 | 1999-11-09 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
| US6090925A (en) | 1993-03-09 | 2000-07-18 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
| NZ260408A (en) | 1993-05-10 | 1996-05-28 | Euro Celtique Sa | Controlled release preparation comprising tramadol |
| US5965161A (en) | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
| US5993856A (en) * | 1997-01-24 | 1999-11-30 | Femmepharma | Pharmaceutical preparations and methods for their administration |
| US6416778B1 (en) | 1997-01-24 | 2002-07-09 | Femmepharma | Pharmaceutical preparations and methods for their regional administration |
| US6287693B1 (en) | 1998-02-25 | 2001-09-11 | John Claude Savoir | Stable shaped particles of crystalline organic compounds |
| GB9819272D0 (en) * | 1998-09-03 | 1998-10-28 | Andaris Ltd | Microparticles |
| SK13742001A3 (sk) | 1999-03-26 | 2002-02-05 | Pozen Inc. | Vysokoúčinné dihydroergotamínové prostriedky |
| DE19940795A1 (de) * | 1999-08-27 | 2001-03-01 | Lohmann Therapie Syst Lts | Schnellzerfallende Pellets auf der Basis von Chitosan |
| ATE288687T1 (de) * | 2001-09-27 | 2005-02-15 | Cognis Deutschland Gmbh | Kugelförmige sterinzubereitungen, deren herstellung und verwendung |
| EP1448228A4 (en) * | 2001-10-24 | 2007-01-24 | Marco Pappagallo | TREATMENT OF POSTOPERATIVE PAIN |
| US8226972B2 (en) * | 2001-12-20 | 2012-07-24 | Femmepharma Holding Company, Inc. | Vaginal delivery of drugs |
| RU2205634C1 (ru) * | 2002-06-18 | 2003-06-10 | Нестерук Владимир Викторович | Лекарственное средство, обладающее противорвотным действием |
| NZ541365A (en) * | 2002-12-27 | 2009-09-25 | Diobex Inc | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
| US7655618B2 (en) * | 2002-12-27 | 2010-02-02 | Diobex, Inc. | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
| MXPA05007266A (es) * | 2003-01-02 | 2006-01-17 | Femmepharma Holding Co Inc | Preparaciones farmaceuticas para tratamientos de enfermedades y trastornos del seno. |
| US9173836B2 (en) | 2003-01-02 | 2015-11-03 | FemmeParma Holding Company, Inc. | Pharmaceutical preparations for treatments of diseases and disorders of the breast |
| ES2340422T3 (es) * | 2003-06-13 | 2010-06-02 | Skendi Finance, Ltd. | Microparticulas constituidas por estradiol y colesterol. |
| US7413690B1 (en) | 2003-10-29 | 2008-08-19 | The University Of Mississippi | Process and apparatus for producing spherical pellets using molten solid matrices |
| US7491263B2 (en) | 2004-04-05 | 2009-02-17 | Technology Innovation, Llc | Storage assembly |
| EP1838716B1 (en) | 2005-01-05 | 2011-06-01 | Eli Lilly And Company | Olanzapine pamoate dihydrate |
| WO2007072491A2 (en) * | 2005-12-21 | 2007-06-28 | Baskaran Chandrasekar | Sustained release pharmaceutical formulation and treatment of ischemic heart disease by administering the same |
| CA2670636A1 (en) | 2006-11-27 | 2008-06-05 | H. Lundbeck A/S | Heteroaryl amide derivatives |
| US20080153789A1 (en) * | 2006-12-26 | 2008-06-26 | Femmepharma Holding Company, Inc. | Topical administration of danazol |
| JP2011516606A (ja) | 2008-04-14 | 2011-05-26 | ポジ ビジョナリー ソリューションズ エルエルピー | 様々な治療指標に必要な血漿プロゲステロン濃度を得るための方法および医薬組成物 |
| RU2395139C1 (ru) * | 2009-04-10 | 2010-07-20 | Российская Федерация, от имени которой выступает Государственная корпорация по атомной энергии "Росатом" | Способ изготовления волновода переменного сечения |
| US20110003000A1 (en) * | 2009-07-06 | 2011-01-06 | Femmepharma Holding Company, Inc. | Transvaginal Delivery of Drugs |
| UY33103A (es) | 2009-12-15 | 2011-07-29 | Techsphere S A De C V | Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico |
| BR112012017136B1 (pt) * | 2010-01-14 | 2021-05-25 | Umecrine Mood Ab | composição farmacêutica compreendendo 3-beta-hidróxi5-alfa-pregnan-20-ona, colesterol e uma mistura de acilgliceróis, método para preparar dita composição farmacêutica, bem como usos da mesma para o tratamento ou prevenção de condições do sistema nervoso central e para cessar a anestesia induzida por esteroide |
| RU2576236C1 (ru) * | 2014-08-22 | 2016-02-27 | Александр Александрович Кролевец | Способ получения нанокапсул антибиотиков в агар-агаре |
| RU2577689C1 (ru) * | 2014-08-26 | 2016-03-20 | Александр Александрович Кролевец | Способ получения нанокапсул антибиотиков в агар-агаре |
| RU2578408C1 (ru) * | 2014-09-10 | 2016-03-27 | Александр Александрович Кролевец | Способ получения нанокапсул алкалоидов |
| ITUB20153652A1 (it) * | 2015-09-16 | 2017-03-16 | Fatro Spa | Microsfere contenenti lattoni macrociclici antielminitici |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE744162A (fr) * | 1969-01-16 | 1970-06-15 | Fuji Photo Film Co Ltd | Procede d'encapsulage |
| US3773919A (en) * | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US3937668A (en) * | 1970-07-15 | 1976-02-10 | Ilse Zolle | Method for incorporating substances into protein microspheres |
| DK123067B (da) * | 1970-09-25 | 1972-05-15 | Niro Atomizer As | Fremgangsmåde til behandling af et pulverformigt, fedtholdigt mælkeprodukt. |
| JPS5017525A (cs) * | 1973-06-14 | 1975-02-24 | ||
| US3982537A (en) * | 1974-12-30 | 1976-09-28 | Louis Bucalo | Dynamic implants and method for implanting the same |
| CA1077842A (en) * | 1975-10-09 | 1980-05-20 | Minnesota Mining And Manufacturing Company | Albumin medicament carrier system |
| IT1202370B (it) * | 1976-07-12 | 1989-02-09 | Hoffmann La Roche | Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti |
| US4357259A (en) * | 1977-08-01 | 1982-11-02 | Northwestern University | Method of incorporating water-soluble heat-sensitive therapeutic agents in albumin microspheres |
| US4244949A (en) * | 1978-04-06 | 1981-01-13 | The Population Council, Inc. | Manufacture of long term contraceptive implant |
| US4384975A (en) * | 1980-06-13 | 1983-05-24 | Sandoz, Inc. | Process for preparation of microspheres |
| US4331654A (en) * | 1980-06-13 | 1982-05-25 | Eli Lilly And Company | Magnetically-localizable, biodegradable lipid microspheres |
| US4349530A (en) * | 1980-12-11 | 1982-09-14 | The Ohio State University | Implants, microbeads, microcapsules, preparation thereof and method of administering a biologically-active substance to an animal |
| FR2524312B1 (fr) * | 1982-04-01 | 1985-10-04 | Tech Cuir Centre | Nouvelles formes de micro-encapsulation de substances medicamenteuses par des couches homogenes de collagene natif |
| US4492720A (en) * | 1983-11-15 | 1985-01-08 | Benjamin Mosier | Method of preparing microspheres for intravascular delivery |
| US4963367A (en) * | 1984-04-27 | 1990-10-16 | Medaphore, Inc. | Drug delivery compositions and methods |
| JPS61174940A (ja) * | 1985-01-29 | 1986-08-06 | Oogawara Kakoki Kk | ワックス類コーテイング単核状マイクロカプセルおよびその製造方法 |
| US4675173A (en) * | 1985-05-08 | 1987-06-23 | Molecular Biosystems, Inc. | Method of magnetic resonance imaging of the liver and spleen |
| IL79407A (en) * | 1985-08-01 | 1991-03-10 | Theragenics Corp | System and method for delivering insoluble material into a living body |
| US4837381A (en) * | 1986-08-11 | 1989-06-06 | American Cyanamid Company | Compositions for parenteral administration and their use |
| ES2039219T3 (es) * | 1986-08-11 | 1993-09-16 | American Cyanamid Company | Composiciones para administracion parenteral y su uso. |
| CA1319886C (en) * | 1987-02-03 | 1993-07-06 | Alberto Ferro | Mixed micelle solutions |
| US4892734A (en) * | 1987-04-06 | 1990-01-09 | Endocon, Inc. | Dispensing paste for forming medicinal pellets |
| US4748024A (en) | 1987-04-06 | 1988-05-31 | Endocon, Inc. | Flash flow fused medicinal implants |
| EP0357644B1 (en) * | 1987-04-06 | 1994-08-17 | Aberlyn Capital Management Limited Partnership | Flash flow fused medicinal implants |
| AU4369589A (en) * | 1988-10-27 | 1990-05-03 | Abbott Laboratories | Controlled-release delivery device, method for producing device, and method of using device |
| US5019400A (en) * | 1989-05-01 | 1991-05-28 | Enzytech, Inc. | Very low temperature casting of controlled release microspheres |
| US5085864A (en) * | 1989-10-30 | 1992-02-04 | Abbott Laboratories | Injectable formulation for lipophilic drugs |
| FR2663223B1 (fr) * | 1990-06-14 | 1994-12-02 | Af Aplicaciones Far Lab | Forme galenique parenterale. |
-
1990
- 1990-06-14 FR FR9007417A patent/FR2663224B1/fr not_active Expired - Fee Related
-
1991
- 1991-06-11 IL IL9845891A patent/IL98458A/en not_active IP Right Cessation
- 1991-06-12 ES ES91910873T patent/ES2068592T3/es not_active Expired - Lifetime
- 1991-06-12 WO PCT/EP1991/001097 patent/WO1991019485A1/fr not_active Ceased
- 1991-06-12 AU AU80667/91A patent/AU643540B2/en not_active Ceased
- 1991-06-12 RO RO92-200136A patent/RO110198B1/ro unknown
- 1991-06-12 DE DE69107026T patent/DE69107026T2/de not_active Expired - Fee Related
- 1991-06-12 RU SU915011663A patent/RU2095055C1/ru active
- 1991-06-12 BR BR919105782A patent/BR9105782A/pt not_active Application Discontinuation
- 1991-06-12 EP EP91910873A patent/EP0487674B1/fr not_active Expired - Lifetime
- 1991-06-12 DK DK91910873.8T patent/DK0487674T3/da active
- 1991-06-12 AT AT91910873T patent/ATE117546T1/de not_active IP Right Cessation
- 1991-06-12 JP JP3510713A patent/JP2690398B2/ja not_active Expired - Lifetime
- 1991-06-12 CA CA002064861A patent/CA2064861C/fr not_active Expired - Fee Related
- 1991-06-12 HU HU9200775A patent/HU219461B/hu not_active IP Right Cessation
- 1991-06-12 KR KR1019920700315A patent/KR0157438B1/ko not_active Expired - Fee Related
- 1991-06-13 SK SK1815-91A patent/SK279867B6/sk unknown
- 1991-06-13 UY UY23239A patent/UY23239A1/es not_active IP Right Cessation
- 1991-06-13 CZ CS19911815A patent/CZ286199B6/cs not_active IP Right Cessation
- 1991-06-13 IE IE201891A patent/IE69172B1/en not_active IP Right Cessation
- 1991-06-14 PL PL91290678A patent/PL167177B1/pl not_active IP Right Cessation
- 1991-06-14 PT PT97976A patent/PT97976B/pt not_active IP Right Cessation
- 1991-06-14 TW TW080104715A patent/TW205511B/zh active
- 1991-06-14 NZ NZ238543A patent/NZ238543A/en not_active IP Right Cessation
- 1991-06-14 TN TNTNSN91047A patent/TNSN91047A1/fr unknown
- 1991-06-14 ZA ZA914549A patent/ZA914549B/xx unknown
- 1991-06-14 PH PH42634A patent/PH30243A/en unknown
- 1991-06-14 CN CN91104858A patent/CN1058608C/zh not_active Expired - Fee Related
-
1992
- 1992-02-13 NO NO92920576A patent/NO920576L/no unknown
- 1992-02-13 BG BG95911A patent/BG61178B1/bg unknown
- 1992-02-13 NO NO920576A patent/NO302927B1/no not_active IP Right Cessation
- 1992-02-14 FI FI920661A patent/FI107697B/fi active
-
1993
- 1993-07-14 US US08/094,579 patent/US5643604A/en not_active Expired - Lifetime
-
1995
- 1995-04-17 GR GR950400939T patent/GR3015809T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL98458A0 (en) | Parenteral dosage form | |
| ZA93929B (en) | A process for the preparation of biologically active materialcontaining polymeric microcapsules. | |
| PL301973A1 (en) | Method of obtaining solution of chemical compounds and method of obtaining n-cyclic and n,n'-bicyclic ureas | |
| CA2041378A1 (en) | Granulated preparations and method of producing the same | |
| HUT70157A (en) | Imidazolylalcenoic acids, pharmaceutical compositions containing them, and process for producing them, and use of them for preparing medicaments | |
| CA2148823A1 (en) | Sustained Release Microsphere Preparation Containing Antipsychotic Drug and Production Process Thereof | |
| EP0235603A3 (en) | Process for forming uniform liquid droplets | |
| EP0414007A3 (en) | A novel arginine deiminase, its manufacturing method and an anti-cancer agent containing this enzyme as an effective ingredient | |
| HU9303749D0 (en) | 2,4-substituted 5-(n-substituted-sulfamoyl)-benzoyl-guanidines, process for producing them, their use as medicine or diagnosticum and pharmaceutical compositions containing them | |
| HU9401092D0 (en) | 5-(acyl-amino)-1,2,4-triadiazole derivatives, pharmaceutical compositions containing them, and process for producing them | |
| EP0714890A3 (de) | Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethyl-piperidin | |
| HUT55762A (en) | Process for producing substituted or unsubstituted 4/5(-)omega-amino-alkyl/-imidazol derivatives and pharmaceutical compositions containing them | |
| HU896135D0 (en) | Process for the preparation of 2-azabicyclo [2.2.1] hept-5-en-2-acetic acid and derivatives thereof | |
| HUT65253A (en) | Process for producing of 1,4-dihydropyridine derivatives and pharmaceutical compositions comprising them | |
| HUT61310A (en) | Process for producing oxopyrrolo/2,3-b/indoleacetic acids, their esters, amides and derivatives, as well as pharmaceutical compositions comprising such compounds as active ingredient | |
| HU9401190D0 (en) | 2,6-disubstituted-4-quinolyl-dihydropyridine derivatives, process for producing them and use of them in pharmaceuticals | |
| HU9300075D0 (en) | Method for producing 1,4-dihydro-pyridine derivatives and pharmaceutical prepartives containing them | |
| Maksak et al. | Contact of Elements of Alloys With" Shape Memory" | |
| Yolton et al. | Gas Atomized Titanium Powder | |
| Bakharev et al. | Approximation of the Dependence of the Melt Viscosity of Thermoplastics on the Temperature and Rate of Shear Using the Williams--Landell--Ferry Equation | |
| Mukas'yan et al. | Regularities of structure formation at ignition of titanium in nitrogen | |
| CS22989A2 (en) | Method of epsilon-caprolactam's modified polymers preparation | |
| Weil et al. | Flame Retardant Polyamides | |
| Ilardo | Chlorine-Containing Flame Retardants. I | |
| CS450189A1 (en) | Method of caprolactam's cyclic oligomers containing mixtures thermical depolymerization |